The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice
Cell Host & Microbe · 2024-05 · 32 (5) · 755-767.e4
DOI: 10.1016/j.chom.2024.03.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Host & Microbe, 2024-05. Verfasst von Sang-Hoon Sin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, N…. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Mice, Transgenic, Hemangiosarcoma, Sarcoma, Kaposi. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, University of North Carolina.
Abstract (Originalsprache)
Kaposi sarcoma (KS) is the most common cancer in persons living with HIV. It is caused by KS-associated herpesvirus (KSHV). There exists no animal model for KS. Pronuclear injection of the 170,000-bp viral genome induces early-onset, aggressive angiosarcoma in transgenic mice. The tumors are histopathologically indistinguishable from human KS. As in human KS, all tumor cells express the viral latency-associated nuclear antigen (LANA). The tumors transcribe most viral genes, whereas endothelial cells in other organs only transcribe the viral latent genes. The tumor cells are of endothelial lineage and exhibit the same molecular pattern of pathway activation as KS, namely phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR, interleukin-10 (IL-10), and vascular endothelial growth factor (VEGF). The KSHV-induced tumors are more aggressive than Ha-ras-induced angiosarcomas. Overall survival is increased by prophylactic ganciclovir. Thus, whole-virus KSHV-transgenic mice represent an accurate model for KS and open the door for the genetic dissection of KS pathogenesis and evaluation of therapies, including vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Laboratory of Veterinary Clinical Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
- National Health Laboratory Service, Division of Anatomical Pathology, Faculty of Medicine and Health Sciences, Tygerberg Hospital, Stellenbosch University, Cape Town, South Africa.
- Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: dirkdittmer@me.com.
Förderung
- NCI NIH HHS
- National Cancer Institute
- University of North Carolina
- NIH
Zitieren
APA
Sin, S. H., Eason, A. B., Kim, Y., Schneider, J. W., Damania, B., & Dittmer, D. P. (2024). The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice. Cell Host & Microbe, 32(5), 755-767.e4. https://doi.org/10.1016/j.chom.2024.03.012
Vancouver
Sin SH, Eason AB, Kim Y, Schneider JW, Damania B, Dittmer DP. The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice. Cell Host & Microbe. 2024;32(5):755-767.e4. doi:10.1016/j.chom.2024.03.012
BibTeX
@article{Sin2024,
author = {Sin, Sang-Hoon and Eason, Anthony B and Kim, Yongbaek and Schneider, Johann W and Damania, Blossom and Dittmer, Dirk P},
title = {The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice},
journal = {Cell Host & Microbe},
year = {2024},
volume = {32},
number = {5},
pages = {755--767.e4},
doi = {10.1016/j.chom.2024.03.012}
}
EUVIMED